Pro Medicus (PRO) Reports H1 2026 Revenue and Profit Up, Announces Q4 Guidance

Pro Medicus (PRO) reported first-half 2026 revenue of $148.3 million, a 12% increase from $132.4 million in the same period of 2025, and adjusted net income of $19.8 million, up 24% year-over-year. The company attributed the gains to higher procedural volumes and pricing optimization. Management provided Q4 2026 guidance of $140–$150 million in revenue and $25–$30 million in adjusted net income, reflecting continued demand in interventional cardiology procedures.